Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease
Public ClinicalTrials.gov record NCT02531113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Open-Label Induction Trial With Extension Period to Access Endoscopic Improvement and Changes in Intestinal and Serum Biomarkers in Patients With Moderately to Severely Active Crohn's Disease Receiving Oral RPC1063 as Induction Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose is to determine whether RPC1063 is effective in the treatment of Crohn's disease.
Study identification
- NCT ID
- NCT02531113
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2015 (Actual)
- Primary completion
- Sep 12, 2019 (Actual)
- Completion
- Nov 28, 2019 (Actual)
- Last update posted
- Jan 22, 2021
2015 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adobe Clinical Research LLC | Tucson | Arizona | 85712 | — |
| Florida Center for Gastroenterology | Largo | Florida | 33777 | — |
| IMIC, Inc. | Palmetto Bay | Florida | 33157 | — |
| Atlanta Gastroenterology Specialists PC | Suwanee | Georgia | 30024 | — |
| DM Clinical Research | Oak Lawn | Illinois | 60453-3767 | — |
| Gastroenterology Associates LLC | Baton Rouge | Louisiana | 70809 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Ehrhardt Clinical Research LLC | Belton | Missouri | 64012 | — |
| UC Health Clinical Trials Office | Cincinnati | Ohio | 45267 | — |
| Ohio State University Clinical Trials Management Office | Columbus | Ohio | 43210 | — |
| Gastroenterology Associates of Orangeburg | Orangeburg | South Carolina | 29118 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| San Antonio Gastroenterology | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02531113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 22, 2021 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02531113 live on ClinicalTrials.gov.